Immediate Impact
1 from Science/Nature 67 standout
Citing Papers
Therapeutic advances in rheumatoid arthritis
2024 Standout
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Works of O. V. Reshetko being referenced
Filgotinib (GLPG0634/GS-6034), an oral selective JAK1 inhibitor, is effective as monotherapy in patients with active rheumatoid arthritis: results from a randomised, dose-finding study (DARWIN 2)
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| O. V. Reshetko | 15 | 46 | 166 | 95 | 72 | 29 | 273 | |
| Samina A. Turk | 13 | 27 | 180 | 54 | 27 | 23 | 279 | |
| H. Deicher | 9 | 37 | 65 | 86 | 53 | 26 | 327 | |
| Wendy Komocsar | 11 | 45 | 102 | 43 | 37 | 28 | 328 | |
| M Pulik | 17 | 48 | 46 | 63 | 35 | 37 | 275 | |
| Émilie Chalayer | 26 | 16 | 56 | 105 | 27 | 29 | 229 | |
| Marta Caprioli | 4 | 100 | 135 | 32 | 27 | 17 | 283 | |
| Jeffrey R. Andolina | 10 | 9 | 79 | 207 | 33 | 29 | 326 | |
| Fernando Campilho | 4 | 95 | 39 | 111 | 82 | 24 | 307 | |
| Maria Atta | 18 | 57 | 96 | 29 | 19 | 21 | 238 | |
| Paul Legendre | 6 | 84 | 65 | 19 | 46 | 29 | 306 |
All Works
Login with ORCID to disown or claim papers
Loading papers...